MOUNJARO DIN 02532948
Health Canada record
| Active ingredient(s) | TIRZEPATIDE 12.5 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A10BX16 TIRZEPATIDE |
| Original market date | |
| Current status date | 24-Nov-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TIRZEPATIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02532891 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 2.5 MG | Approved |
| 02532905 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 5 MG | Approved |
| 02532913 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 7.5 MG | Approved |
| 02532921 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 10 MG | Approved |
| 02532956 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 15 MG | Approved |
| 02541041 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 2.5 MG | Marketed |
| 02541068 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 5 MG | Marketed |
| 02541076 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 7.5 MG | Marketed |
| 02541084 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 10 MG | Marketed |
| 02541092 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 12.5 MG | Marketed |
| 02541106 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 15 MG | Marketed |
| 02551950 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 2.5 MG | Marketed |
| 02551969 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 5 MG | Marketed |
| 02551977 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 7.5 MG | Marketed |
| 02551985 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 10 MG | Marketed |
| 02551993 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 12.5 MG | Marketed |
| 02552000 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 15 MG | Marketed |
| 02557509 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 2.5 MG | Marketed |
| 02557517 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 5 MG | Marketed |
| 02557525 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 7.5 MG | Marketed |
| 02557533 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 10 MG | Marketed |
| 02557541 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 12.5 MG | Marketed |
| 02557568 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 15 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29535 | 2022-11-24 | New Drug Submission (NDS) |
International API supply for TIRZEPATIDE
40 active FDA Drug Master Files.
Request a quote for MOUNJARO